Market access & reimbursement
- Analyze relevant clinical data, expected by HTA bodies.
- Elaborate strategic recommendations.
•Secure market access based on expertise and relationships.
- Define value proposition for innovative technologies and optimize landscape of assessments.
- Manage reimbursement dossiers, realize critical review of HTA evaluations, set up action plan with key stakeholders.
Pricing strategies & outcomes
- Analyze pricing and coding on French healthcare database (PMSI).
- Define pricing strategy and operational actions from the payers
- Conduct pricing readiness workshops.
- Elaborate budget impact models (BIM).
- Negotiate reimbursement tariff with payers.
Public affairs & stakeholder management
- Carry out stakeholder mappings.
- Maintain our network of experts and key opinion leaders from varied therapeutic areas
- Collaborate actively with key players and decision makers.
- Organise key opinion leader interviews and advisory board.
- Prepare HTA appeal for health technoligies.
- Organise regulatory communications for market access.
- Secure National funding programs: authorization of submission for clinical trial.
- Interract with qualified institutions : National Agency for Medicines and Health Products Safety (ANSM), People protection Authority (CPP), Data Protection Authority (CNIL)
- Offer Regulatory intelligence / Customized newsletter.
SGE Consulting offers training in academic and professional fields on market access and reimbursement for innovative health technologies (Université Paris-Saclay, IPIL in Lyon, ISIFC in Franche Comté…).
→ More information, contact us